Despite the many ergonomic advantages of eccrine perspiration (sweat) compared to other possible biofluids (particularly in “wearable” devices), sweat remains an underrepresented source of biomarker analytes compared to blood, urine, and saliva. Upon closer comparison to other non-invasive biofluids, the advantages may even extend beyond ergonomics: sweat might provide superior analyte information. A number of challenges, however, have historically kept sweat from assuming a more prominent place among clinical sampling modalities. These challenges include very low sample volumes (nL to μL), unknown concentration due to evaporation, filtration and dilution of large analytes, mixing of old and new sweat, and the potential for contamination from the skin surface. More recently, rapid progress in wearable sweat sampling and sensing devices has resolved several of these historical challenges. However, this recent progress has also been limited to high concentration analytes (μM to mM) sampled at high sweat rates (>1 nL/min/gland, e.g. athletic applications). Progress will become much more challenging as sweat biosensing moves towards use with sedentary users (low sweat rates or not sweating at all) and/or towards low concentration analytes (pM to nM). Furthermore, the solutions to resolving these problems will be highly multidisciplinary, and may require source components that will be very dissimilar in their manufacturing infrastructure or cost profile. As a result, monolithic integration of all materials and components in a sweat sensing device, in many circumstances may be impractical, or render certain applications prohibitively expensive. Furthermore, some materials and components may be needed for nearly all sweat sensing applications, whereas other materials and components would be needed only for niche applications. In such cases, modular techniques are required to allow efficient integration of broadly applicable materials, or components with niche application materials or components. Additionally, modular techniques may allow the distribution of expensive components among disposable and reusable modules, or can allow one-use or limited-use components to be efficiently combined with components capable of longer lifespan.
Many of the drawbacks and limitations currently facing sweat sensing and other biofluid sensing modalities can be resolved by creating novel and advanced interplays of chemicals, materials, sensors, electronics, microfluidics, algorithms, computing, software, systems, and other features or designs, in a manner that affordably, effectively, conveniently, intelligently, or reliably brings biofluid to sensors and to biofluid preparing or concentrating subsystems. By doing do, sweat sensing could become a much more compelling paradigm as a biosensing platform, and other biofluid sensing modalities can be improved.
The disclosed invention provides a wearable biofluid sensing device configured for the modular distribution and assembly of a variety of subsystems, components, and materials. These include the modular distribution of components based on biofluid sensing device application, manufacturing considerations, cost considerations, and component lifespan.
The objects and advantages of the present invention will be further appreciated in light of the following detailed descriptions and drawings in which:
Before continuing with the background, a variety of definitions should be made, these definitions gaining further appreciation and scope in the detailed description and embodiments of the present disclosure.
As used herein, “sweat” means a biofluid that is primarily sweat, such as eccrine or apocrine sweat, and may also include mixtures of biofluids such as sweat and blood, or sweat and interstitial fluid, so long as advective transport of the biofluid mixtures (e.g., flow) is primarily driven by sweat.
As used herein, “biofluid” may mean any human biofluid, including, without limitation, sweat, interstitial fluid, blood, plasma, serum, tears, and saliva.
“Biosensor” means any type of sensor that measures a state, presence, flow rate, solute concentration, solute presence, in absolute, relative, trending, or other ways in a biofluid. Biosensors can include, for example, potentiometric, amperometric, impedance, optical, mechanical, antibody, peptide, aptamer, or other means known by those skilled in the art of sensing or biosensing.
“Analyte” means a substance, molecule, ion, or other material that is measured by a fluid sensing device.
“Measured” can imply an exact or precise quantitative measurement and can include broader meanings such as, for example, measuring a relative amount of change of something. Measured can also imply a binary or qualitative measurement, such as ‘yes’ or ‘no’ type measurements.
“Chronological assurance” means the sampling rate or sampling interval that assures measurement(s) of analytes in sample in terms of the rate at which measurements can be made of new fluid analytes as they enter the sample. Chronological assurance may also include a determination of the effect of sensor function, potential contamination with previously generated analytes, other fluids, or other measurement contamination sources for the measurement(s). Chronological assurance may have an offset for time delays in the body (e.g., a well-known 5- to 30-minute lag time between analytes in blood emerging in interstitial fluid), but the resulting sampling interval is independent of lag time, and furthermore, this lag time is inside the body, and therefore, for chronological assurance as defined above and interpreted herein, this lag time does not apply.
As used herein, “continuous monitoring” means the capability of a device to provide at least one measurement of sweat determined by a continuous or multiple collection and sensing of that measurement or to provide a plurality of measurements of sweat over time.
“Biofluid sensor data” means all the information collected by fluid sensing device sensor(s) and communicated to a user or a data aggregation location.
“Correlated aggregated fluid sensor data” means fluid sensor data that has been collected in a data aggregation location and correlated with outside information such as time, temperature, weather, location, user profile, other biofluid sensor data, or any other relevant data.
“Sweat generation rate” is the rate at which sweat is generated by the sweat glands themselves. Sweat generation rate is typically measured by the flow rate from each gland in nL/min/gland. In some cases, the measurement is then multiplied by the number of sweat glands from which the sweat is being sampled.
“Sweat volume” is the fluidic volume in a space that can be defined multiple ways. Sweat volume may be the volume that exists between a sensor and the point of generation of sweat or a solute moving into or out of sweat from the body or from other sources. Sweat volume can include the volume that can be occupied by sweat between: the sampling site on the skin and a sensor on the skin where the sensor has no intervening layers, materials, or components between it and the skin; or the sampling site on the skin and a sensor on the skin where there are one or more layers, materials, or components between the sensor and the sampling site on the skin.
“Microfluidic components” are channels in polymer, textiles, paper, or other components known in the art of microfluidics for guiding movement of a fluid or at least partial containment of a fluid.
“Sweat sampling rate” is the effective rate at which new sweat or sweat solutes, originating from the sweat gland or from skin or tissue, reaches a sensor which measures a property of sweat or its solutes. Sweat sampling rate, in some cases, can be far more complex than just sweat generation rate.
“Sweat stimulation” is the direct or indirect causing of sweat generation by any external stimulus, the external stimulus being applied for the purpose of stimulating sweat. One example of sweat stimulation is the administration of a sweat stimulant such as pilocarpine. Going for a jog, which stimulates sweat, is only sweat stimulation if the subject jogging is jogging for the purpose of stimulating sweat.
As used herein, “microfluidic components” are channels in polymer, textiles, paper, or other components known in the art of microfluidics for guiding movement of a fluid or at least partial containment of a fluid.
As used herein, “advective transport” is a transport mechanism of a substance or conserved property by a fluid due to the fluid's bulk motion.
“Diffusion” means the net movement of a substance from a region of high concentration to a region of low concentration. This is also referred to as the movement of a substance down a concentration gradient.
A “module” is a component or components which are fabricated individually and integrated with at least one other modeling during assembly of a sweat sensing device.
“Volume reducing component” means any component which reduces the sweat volume as taught in PCT/US15/32893, which is hereby incorporated by reference herein in its entirety.
“Volume reducing wicking component” means any component as taught in PCT/US16/43771, which is hereby incorporated by reference herein in its entirety.
“Sweat stimulating component” means any component as taught in PCT/US14/61083, PCT/US16/17726, U.S. Ser. No. 15/186,925, and PCT/US16/50928, which are hereby incorporated by reference herein in their entirety.
“Electroporation component” means any component as taught in PCT/US17/13453, which is hereby incorporated by reference herein in its entirety.
“Sensor component” means any component or components which measure a solute in sweat, a property of sweat, or the presence of sweat. Sensors can be thermal, flow, impedance, potentiometric, ion-selective, amperometric, enzymatic, aptamer, antibody, fluorescent, colorimetric, surface-plasmon resonance, acoustic, resonant, MEMs, or any other sensor suitable for sensing sweat in at least one measurement.
“Flow rate sensor” means any component or components which measure the flow rate of sweat or other biofluid in at least one portion of a biofluid sensing device.
“Primary module” means any component or components that may contain “sensor components”, “stimulating components”, “volume reducing components”, and/or “volume reducing wicking components”.
“Sensing module” means any component or components fabricated separately from the primary module and specialized module, that provides one or more generally applicable sensors, such as one or more ion-selective electrodes, a biofluid flow rate sensor, a pH sensor, a temperature sensor, a galvanic skin response sensor, or a skin impedance sensor.
“Specialized module” means any component or components, fabricated separately from the primary module and sensing module, that provides a specialized and application-specific purpose in a biofluid sensing device, such as one or more electrochemical aptamer-based sensors, ion-selective electrode sensors; amperometric sensor, potentiometric sensor, enzymatic sensor, antibody sensor, optical sensor, surface-plasmon sensor, acoustic sensor, resonant sensor, micro-electro-mechanical MEMs sensor, biofluid sample concentration component, osmotic pump component, wicking component, or a sample collection and storage component, including those as taught in PCT/US16/58356, and PCT/US17/23399 which are hereby incorporated by reference herein in their entirety.
With reference to
With reference to
With reference to
With reference to
With reference to
To illustrate the modular nature of component distribution and assembly, the primary module 310 is, e.g., a disposable microfluidic wicking component, that interfaces with the reusable sensing module 320 and its sensors 322, 324, 326, by pressing the primary module against the sensing module, and securing the modules together by means of a simple mechanical interaction, such as an adhesive or click attachment means. Interfacing the primary module 310 with the sensing module 320 thus puts the wicking component in fluid communication with the sensors 322, 324, 326. An optional hydrogel or other wicking material 329 can be placed between at least one of the sensors 322, 324, 326 and wick 310, to improve the transfer of biofluid sample or biofluid analytes from the wick 310 to the sensors 322, 324, 326. Additionally, a reusable specialized module 330 is connected to the primary module 310 by means similar to the connection of the primary module to the sensing module, e.g., by simple physical contact or a mechanical interaction, so that the wick is in fluid communication with the specialized module. In some embodiments, the device includes a vapor barrier layer (not shown) over primary module 310, which prevents or reduces biofluid sample evaporation out of the device. In other embodiments, a vapor barrier layer (not shown) could be located above the substrate 350 and below the sensors 322, 324, 326 to prevent vapor from escaping once it has entered the device. Alternatively, the device may have both such vapor barrier layers, which may be separate component(s) or ray be manufactured/integrated with the substrate 350, the primary module 310, or another module as necessary. Alternatively, the sensing module 320 could have its own microfluidic component that is placed in fluidic communication with both the primary module and the specialized module (not shown).
With reference to
With reference to
With reference to
With reference to
With further reference to
In some embodiments, the electroporation electrode 414 can also function as a skin impedance sensor, which can provide information useful for controlling the electroporation or sweat stimulation functions. The wicking volume reducing component 410 transports stimulated sweat from the skin surface and carries the sweat sample to the sensing module sensors 422, 424, which would measure, e.g., Na+, K+, and pH. The sensing module may also include a sweat flow rate sensor. The wicking component 410 then transports the sweat sample to the specialized module sensors 432, which are EAB sensors for vasopressin. The vasopressin will be concentrated as water and small sweat solutes are transported through the forward osmosis membrane 437, into the osmosis material 436, and out of the sweat sample. Because the sweat sample will gradually increase in vasopressin concentration as the sample moves toward the pump 439, the sensors in the sensor suite 432 will see increasing amounts of vasopressin. By measuring vasopressin concentration with three sensors (each with ˜80× linear range), and with a measured sweat flow rate, the device determines the original sweat sample concentration of vasopressin. Finally, wicking pump 439, which could have a total wicking capacity of 10's to 100's of μL, absorbs the sweat sample, and at least partially pulls sweat sample flow through the device.
Embodiments of the present invention may be useful for a variety of sweat sensing applications. For example, low sweat rates enabled by embodiments of the present invention can also allow otherwise impractical sensing of some solutes. For example, a large sweat rate can cause sweat glands to generate significant quantities of lactate, making correlation between sweat lactate concentration and blood concentration impossible. Because embodiments of the disclosed invention are capable of detecting lactate at very low sweat generation rates, blood lactate that partitions into sweat can dominate over lactate generated by the sweat gland. Therefore, embodiments of the present invention enable improved sweat-based estimates of blood lactate. Embodiments of the present invention could also help in sensing of cytokines, which partition into sweat very slowly and require low sweat rates for accurate sweat concentrations that can be correlated with blood levels. Embodiments of the disclosed invention also improve other sensing applications by reducing the amount of stimulation needed for a given chronologically assured sampling interval by reducing the sweat volume needed by the sensors, which reduces needed sweat generation rate to refresh that sweat volume. Similarly, the present invention could also reduce the time for a new concentration of biomarkers to move from blood into sweat and onto the sensors, therefore providing sweat measurements that are closer to real time blood concentrations.
This has been a description of the disclosed invention along with a preferred method of practicing the invention, however the invention itself should only be defined by the appended claims.
This application relates to U.S. Provisional No. 62/364,939, filed Jul. 21, 2016, the disclosure of which is hereby incorporated by reference herein in its entirety.
The present invention was made outside any support from the U.S. Government.
Number | Date | Country | |
---|---|---|---|
62364939 | Jul 2016 | US |